April 30, 2019
PolyProx Therapeutics raises £3.4m seed capital to boost new cancer drugs
Seed will enable growth of the PolyProx team and furtherdevelop our technology over the next two years
Pharmaceuticals, Biotechnology and Life Sciences
Tag: PolyProx Therapeutics